“…The abundance of DE ncRNAs in PA has been widely reported. Investigating the roles of ncRNAs is helpful for understanding the occurrence and development of PA, and some ncRNAs can be used as biomarkers for the detection of PA [ 1 , 18 , 43 , 127 ], while other ncRNAs can contribute to the diagnosis of PA [ 52 , 85 , 90 , 112 ], distinguish the disease subtypes [ 24 , 25 , 34 , 93 ], and predict tumor invasion and progression [ 20 , 26 , 35 , 85 , 95 , 110 , 111 , 123 ]; the remaining ncRNAs may be implicated in the pathogenesis of PA [ 116 , 117 , 120 , 122 ]. In addition, the regulatory networks of lncRNA/circRNA and miRNA provide promising biomarkers for the noninvasive diagnosis and molecular therapy of PA, and exosome-derived ncRNAs bring a tremendous infusion of hope to the improvement of the disease diagnosis and future potential therapeutic targets for treatments.…”